These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6770239)

  • 1. Estimate of the risk in radiation therapy due to unwanted neutrons.
    Swanson WP
    Med Phys; 1980; 7(2):141-4. PubMed ID: 6770239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrons from high-energy x-ray medical accelerators: an estimate of risk to the radiotherapy patient.
    Nath R; Epp ER; Laughlin JS; Swanson WP; Bond VP
    Med Phys; 1984; 11(3):231-41. PubMed ID: 6429495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unwanted radiation produced by leakage neutrons from medical electron accelerators.
    Ing H; Shore RA
    Med Phys; 1982; 9(1):34-6. PubMed ID: 6804770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of the neutron leakage from a dedicated intraoperative radiation therapy electron linear accelerator and a conventional linear accelerator for 9, 12, 15(16), and 18(20) MeV electron energies.
    Jaradat AK; Biggs PJ
    Med Phys; 2008 May; 35(5):1711-7. PubMed ID: 18561646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photonuclear dose calculations for high-energy photon beams from Siemens and Varian linacs.
    Chibani O; Ma CM
    Med Phys; 2003 Aug; 30(8):1990-2000. PubMed ID: 12945965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fast neutrons from a 25-MeV betatron.
    Fox JG; McAllister JD
    Med Phys; 1977; 4(5):387-96. PubMed ID: 409919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential hazard due to induced radioactivity secondary to radiotherapy: the report of task group 136 of the American Association of Physicists in Medicine.
    Thomadsen B; Nath R; Bateman FB; Farr J; Glisson C; Islam MK; LaFrance T; Moore ME; George Xu X; Yudelev M
    Health Phys; 2014 Nov; 107(5):442-60. PubMed ID: 25271934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The RBE of the leakage radiation from the Hiletron neutron therapy unit.
    Chen F; Hendry JH; Chu G; Greene D; Bianchi M
    Br J Radiol; 1983 Aug; 56(668):551-8. PubMed ID: 6409200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk assessment for cancer induction after low- and high-LET therapeutic irradiation.
    Engels H; Menzel HG; Pihet P; Wambersie A
    Strahlenther Onkol; 1999 Jun; 175 Suppl 2():47-51. PubMed ID: 10394397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation protection aspects of a new high-energy linear accelerator.
    O'Brien P; Michaels HB; Gillies B; Aldrich JE; Andrew JW
    Med Phys; 1985; 12(1):101-7. PubMed ID: 3919249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characteristics of the RBE of a therapeutic beam of fast neutrons from a U-120 cyclotron].
    Gul'ko GM; Bezdrobnaia LK; Chernichenko VA
    Radiobiologiia; 1988; 28(1):73-5. PubMed ID: 3125563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutron flux-density and secondary-particle energy spectra at the 184-inch synchrocyclotron medical facility.
    Smith AR; Schimmerling W; Kanstein LL; McCaslin JG; Thomas RH
    Med Phys; 1981; 8(5):668-76. PubMed ID: 6793821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neutron Dosimetry System Using CR-39 for High-energy X-ray Radiation Therapy].
    Yabuta K; Monzen H; Tamura M; Tsuruta T; Itou T; Nohtomi A; Nishimura Y
    Igaku Butsuri; 2014; 34(3):139-48. PubMed ID: 26288880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The RBE for mouse skin irradiated with 3-MeV neutrons: single and fractionated doses.
    Joiner MC; Maughan RL; Fowler JF; Denekamp J
    Radiat Res; 1983 Jul; 95(1):130-41. PubMed ID: 6878624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutron leakage measurements from a medical linear accelerator.
    Palta JR; Hogstrom KR; Tannanonta C
    Med Phys; 1984; 11(4):498-501. PubMed ID: 6434916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose levels due to neutrons in the vicinity of high-energy medical accelerators.
    McGinley PH; Wood M; Mills M; Rodriguez R
    Med Phys; 1976; 3(6):397-402. PubMed ID: 826776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorus activation neutron dosimetry and its application to an 18-MV radiotherapy accelerator.
    Bading JR; Zeitz L; Laughlin JS
    Med Phys; 1982; 9(6):835-43. PubMed ID: 6819434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the production of neutrons in laminated barriers for 10 MV medical accelerator rooms.
    Facure A; da Silva AX; da Rosa LA; Cardoso SC; Rezende GF
    Med Phys; 2008 Jul; 35(7):3285-92. PubMed ID: 18697553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurements of the neutron dose equivalent for various radiation qualities, treatment machines and delivery techniques in radiation therapy.
    Hälg RA; Besserer J; Boschung M; Mayer S; Lomax AJ; Schneider U
    Phys Med Biol; 2014 May; 59(10):2457-68. PubMed ID: 24778349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multileaf shielding design against neutrons produced by medical linear accelerators.
    Rebello WF; Silva AX; Facure A
    Radiat Prot Dosimetry; 2008; 128(2):227-33. PubMed ID: 17569690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.